Our Research

Housed at the Vancouver Prostate Centre, PC-TRIADD’s world-class research aims to understand mechanisms of treatment resistance in advanced prostate cancer and translate that into new services and products to improve cancer outcomes.

Our Services

Leveraging its research expertise, core facilities and project management experience, PC-TRIADD offers pharmaceutical companies, biotech companies and researchers a variety of translational research services including Pre-clinical Pharmacology, Applied Genomics, Micorarray and Clinical Trials.

About Us

PCTRIADD, a translational research initiative of the Vancouver Prostate Centre, is dedicated to improving outcomes in prostate cancer. PC-TRIADD host institutions are the Vancouver Coastal Health Research Institute and the Faculty of Medicine at the University of British Columbia.

Partnerships

As with any successful research enterprise the key to success is establishing and maintaining strong networks and partnerships with local, national, and international collaborators, as well as funders, patients and benefactors.

Highlights

Announcement

Pfizer announced a three-year, $9-million research collaboration with the Vancouver Prostate Centre and BC Cancer Agency.

News

22/11/2011

Vancouver Prostate Centre partners with Step Into Action

Vancouver Prostate Centre is proud to partner...

27/10/2011

Robert H.N. Ho Research Centre Now Open

Focusing on early detection and disease...